Bacterial resistance to antiseptics requires surveillance system -- advisory cmte.
This article was originally published in The Tan Sheet
Executive Summary
BACTERIAL ANTISEPTIC RESISTANCE SURVEILLANCE SYSTEM NEEDED as part of the plan to regulate antiseptic handwashes, suggested Lynn McKinley-Grant, MD, Washington, D.C. Hospital Center, at a Jan. 22 joint meeting of FDA's Nonprescription Drugs and Anti-infective Drugs Advisory Committees in Gaithersburg, Md. "There probably will need to be a method in the healthcare continuum model" proposed by industry for regulation of antiseptic handwash products to "evaluate bacterial [resistance] on a continuing basis," McKinley-Grant, a member of NDAC, said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning